ArticleFrontiers in cellular and infection microbiology2026
Heterogeneity in the association between gut microbiota and insomnia moderated by Parkinson's disease status.
Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Parkinson's disease (PD) is frequently accompanied by insomnia, and emerging evidence suggests the gut microbiome may play a role. This study investigates gut microbiome differences associated with insomnia in PD patients compared to non-PD individuals. Methods: We analyzed 310 participants (185 PD patients, 125 controls) categorized by insomnia status. Gut microbiome profiles were obtained using 16S rRNA sequencing and processed with DADA2 using the SILVA database for taxonomic assignment. Alpha and beta diversity analyses and differential abundance analysis were conducted, and functional prediction was performed using PICRUSt2, adjusting for relevant confounders. Results: Insomnia was linked to higher alpha diversity in non-PD individuals but lower alpha diversity in PD patients. Interaction analysis confirmed distinct associations between insomnia and microbial diversity in the two groups. Differential abundance analysis identified unique insomnia-associated bacterial genera, with differing insomnia-risk-reducing and insomnia-risk-increasing taxa. Functional analysis showed six enriched pathways in controls but only two in PD patients, with no overlap. Discussion: These findings suggest that insomnia in PD is associated with distinct gut microbiome profiles compared with non-PD individuals. The results highlight the importance of considering disease context when examining microbiome-sleep relationships and may inform future research on microbiome-based approaches for sleep disturbances in PD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.